Assessment of Early Outcomes of Roflumilast in Patients With Non Cystic Fibrosis Bronchiectasis
Status:
Unknown status
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
Aim of the work
Assessment of early outcome of using Roflumilast in patients with bronchiectasis regarding:
- Severity of symptoms
- Frequency of exacerbations
- Change in pulmonary function
- Systemic inflammation